[1]CurrentPatentAssignee:NATIONALCANCERCENTERJAPAN;DAEGUGYEONGBUKMEDICALINNOVATIONFOUNDATION-KR2019/109007,2019,ALocationinpatent:Paragraph0325;0328-0330
63843-58-3
333954-89-5
76579-64-1
1072944-50-3
1403483-71-5
3413-27-2
67-99-2 | Gliotoxin | AA006149 | MFCD00058534
936074-87-2 | (2-[1,2,4]Triazolo[3,4-b][1,3,4]thiadiazol-6-ylphenyl)amine | AA0061US | MFCD02249079
72651-98-0 | 1,3-Dioxane-4,6-dione,5-(1H-indol-3-ylmethyl)-2,2-dimethyl- | AA0062RJ | MFCD00012078
68462-57-7 | (2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-nitrophenoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | AA0063FU | MFCD04116190
925456-54-8 | Benzenemethanol, 4-[(1r)-1-aminoethyl]- | AA0064CY | MFCD11042401
99-51-4 | 1,2-dimethyl-4-nitrobenzol | AA00653G | MFCD00007268
69815-95-8 | 5-Methylfuran-2-sulfonyl chloride | AA0065XZ | MFCD11109334
94971-19-4 | 5-Morpholino-4-phenyl-4H-1,2,4-triazole-3-thiol | AA0066TN | MFCD06655830
948291-36-9 | 2,5-Dichloro-8-methylquinoline-3-carboxaldehyde | AA0067NV | MFCD09787537
96-18-4 | 1,2,3-Trichloropropane | AA0068HR | MFCD00000946